Status: Terminated
ClinicalTrials.gov Identifier: NCT01577381
Pfizer B1181003: Multiple doses of RN6G by infusion in patients with Geograpic Atrophy secondary to Age-Related Macular Degeneration.
Condition: Age-Related Maculopathy
Study Type: Interventional
Duration: 14 months
Eligibility:
For additional information on this study, please click here
Status: Completed
ClinicalTrials.gov Identifier: NCT01010997
Foresee Home Device: Intended for the early detection of AMD.
Condition: Age-Related Macular Degeneration
Study Type: Observational
Duration: 3 years
Eligibility:
For additional information on this study, please click here
Back to Clinical Research